Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Graduate Medical Education
|
January 9, 2019
Discharge Summary
Bailey Fitzgerald
Journal of Cancer Metastasis and Treatment
|
June 19, 2024
The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas
Michael Offin, Bailey Fitzgerald, Marjorie G Zauderer, et al.
Journal of Investigative Medicine High Impact Case Reports
|
May 29, 2019
Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System
Yuxin Liu, Bailey Fitzgerald, Edward Perry, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 25, 2026
A Phase 1/1b Study of Direct Intratumoral Injection of Pleural Mesothelioma of Immunostimulant Prior to Surgical Resection
Andrea S Wolf, Shubham Gulati, Komal Dolasia, et al.
JCI Insight
|
August 26, 2025
Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth control
Akhil Goud Pachimatla, Bailey Fitzgerald, Joyce Ogidigo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 16, 2025
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
Hongcheng Zhu, Said Al Saifi, Houda Bahig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC
Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study
Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Graduate Medical Education
|
January 9, 2019
Discharge Summary
Bailey Fitzgerald
Journal of Cancer Metastasis and Treatment
|
June 19, 2024
The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas
Michael Offin, Bailey Fitzgerald, Marjorie G Zauderer, et al.
Journal of Investigative Medicine High Impact Case Reports
|
May 29, 2019
Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System
Yuxin Liu, Bailey Fitzgerald, Edward Perry, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 25, 2026
A Phase 1/1b Study of Direct Intratumoral Injection of Pleural Mesothelioma of Immunostimulant Prior to Surgical Resection
Andrea S Wolf, Shubham Gulati, Komal Dolasia, et al.
JCI Insight
|
August 26, 2025
Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth control
Akhil Goud Pachimatla, Bailey Fitzgerald, Joyce Ogidigo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 16, 2025
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
Hongcheng Zhu, Said Al Saifi, Houda Bahig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC
Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study
Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Page
of 1